CoChat
Sign Up
Cited by 16Diabetes Management and ResearchAttention Deficit Hyperactivity DisorderDiabetes Management and Education

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Impact of attention deficit hyperactivity disorder on metabolic control in adolescents with type1 diabetes

Macek, Jerneja, Battelino, Tadej, Bizjak, Masa, Zupanc, Cita, Bograf, Ana Kovac, Vesnic, Sabina, Klemencic, Simona, Volk, Eva, Bratina, Natasa·2019·Journal of Psychosomatic Research
DOI 10.1016/j.jpsychores.2019.109816
Open this paper in CoChat — free account

Abstract

Objective Diabetes mellitus type 1 (T1D) incidence is increasing in pediatric population. Good metabolic control, measured by glycated hemoglobin (HbA 1c), significantly reduces the risk for chronic complications. Comorbid disorders, including attention-deficit hyperactivity disorder (ADHD), may influence glycemic control. To date little is known about the prevalence of ADHD among adolescents with T1D and its influence on diabetes self-management. Therefore, we aimed to identify adolescents with T1D and ADHD and assess the effect of ADHD on metabolic control. Method This cross-sectional case-control study included 101 patients (11-17 years old) with T1D. Development and Well-Being Assessment (DAWBA) questionnaire and subsequent psychiatric clinical examination were used to identify ADHD in a group with T1D. Indicators of metabolic control were collected from available medical documentation for preceding 12 months and compared between the group of patients with T1D and ADHD and the group of T1D patients without ADHD. Results ADHD was diagnosed in 11.9% adolescents with T1D (12 of 101). We found a statistically significant difference (p = .022) in HbA 1c between the two groups - higher in the group with T1D and ADHD (8.4% or 68.3 mmol/mol) than in the group with T1D without ADHD (7.8% or 61.7 mmol/mol). Conclusions Almost 12% of adolescents with type 1 diabetes were diagnosed with ADHD and they had poorer glycemic control. Adolescents with T1D and ADHD must be diagnosed early and offered appropriate treatment focused on preventing negative ADHD impact on metabolic control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpsychores.2019.109816

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Craig, 2009, Definition, epidemiology and classification of diabetes in children and adolescents, Pediatr. Diabetes, 10, 3, 10.1111/j.1399-5448.2009.00568.x · DOI
  2. Maahs, 2010, Epidemiology of type 1 diabetes, Endocrinol. Metab. Clin. N. Am., 39, 481, 10.1016/j.ecl.2010.05.011 · DOI · Paper page
  3. Radosevic, 2013, The incidence of type 1 diabetes in republic of Srpska (Bosnia and Herzegovina) and Slovenia in the period 1998-2010, Pediatr. Diabetes, 14, 273, 10.1111/j.1399-5448.2012.00898.x · DOI
  4. 1994, J. Pediatr., 125, 177, 10.1016/S0022-3476(94)70190-3 · DOI · Paper page
  5. Rewers, 2014, ISPAD clinical practice consensus guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes, Pediatr. Diabetes, 15, 102, 10.1111/pedi.12190 · DOI · Paper page
  6. Spencer, 1999, Attention-deficit/hyperactivity disorder and comorbidity, Pediatr. Clin. N. Am., 46, 915, 10.1016/S0031-3955(05)70163-2 · DOI
  7. Cameron, 2014, ISPAD Clinical Practice Consensus Guidelines 2014. Diabetes in adolescence, Pediatr. Diabetes, 15, 245, 10.1111/pedi.12169 · DOI
  8. Sun, 2018, Genetic variant for behavioral regulation factor of executive function and its possible brain mechanism in attention deficit hyperactivity disorder, Sci. Rep., 8, 7620, 10.1038/s41598-018-26042-y · DOI
  9. Nylander, 2018, Self- and parent-reported executive problems in adolescents with type 1 diabetes are associated with poor metabolic control and low physical activity, Pediatr. Diabetes, 19, 98, 10.1111/pedi.12520 · DOI
  10. Hilgard, 2017, Comorbidity of attention deficit hyperactivity disorder and type 1 diabetes in children and adolescents: analysis based on the multicentre DPV registry, Pediatr. Diabetes, 18, 706, 10.1111/pedi.12431 · DOI · Paper page
  11. Butwicka, 2015, Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study, Diabetes Care, 38, 453, 10.2337/dc14-0262 · DOI · Paper page
  12. Chen, 2013, Association of attention-deficit/hyperactivity disorder with diabetes: a population-based study, Pediatr. Res., 73, 492, 10.1038/pr.2013.5 · DOI
  13. Sivertsen, 2014, Mental health in adolescents with type 1 diabetes: results form a large population – based study, BMC Endocr. Disord., 14, 83, 10.1186/1472-6823-14-83 · DOI
  14. Ji, 2018, Type 1 diabetes in parents and risk of attention deficit/hyperactivity disorder in offspring: a population-based study in Sweden, Diabetes Care, 41, 770, 10.2337/dc17-0592 · DOI
  15. Nylander, 2018, Previously undiagnosed attention-deficit/hyperactivity disorder associated with poor metabolic control in adolescents with type 1 diabetes, Pediatr. Diabetes, 19, 816, 10.1111/pedi.12651 · DOI
  16. Yazar, 2019, The effect of attention deficit/hyperactivity disorder and other psychiatric disorders on the treatment of pediatric diabetes mellitus, Pediatr. Diabetes, 20, 345, 10.1111/pedi.12819 · DOI · Paper page
  17. Lin, 2018, Association of attention deficit hyperactivity disorder with recurrent hypoglycemia in type 1 diabetes mellitus, Pediatr. Diabetes, 20, 189, 10.1111/pedi.12716 · DOI
  18. Wolfsdorf, 2014, ISPAD clinical practice consensus guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state, Pediatr. Diabetes, 15, 154, 10.1111/pedi.12165 · DOI
  19. Ly, 2014, ISPAD clinical practice consensus guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes, Pediatr. Diabetes, 15, 180, 10.1111/pedi.12174 · DOI
  20. Foreman, 2009, Exploring the clinical utility of the development and well-being assessment (DAWBA) in the detection of hyperkinetic disorders and associated diagnoses in clinical practice, Child Psychol. Psychiatry, 50, 460, 10.1111/j.1469-7610.2008.02017.x · DOI
  21. Wandell, 2013, Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden, Curr. Diabetes Rev., 9, 342, 10.2174/15733998113099990064 · DOI
  22. Pastor, 2002, Attention deficit disorder and learning disability: United States, 1997-98, Vital Health Stat., 10, 206): 1
  23. Bratina, 2015, Type 1 diabetes in the young: Organization of two National Centers in Israel and Slovenia, ZdrVarst, 54, 139
  24. Neumark-Sztainer, 2002, Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes, Diabetes Care, 25, 1289, 10.2337/diacare.25.8.1289 · DOI
  25. Schoenaker, 2014, Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB prospective complications study, J. Clin. Endocrinol. Metab., 99, 800, 10.1210/jc.2013-2824 · DOI · Paper page
  26. Lindblad, 2015, Fasting blood glucose and HbA1c in children with ADHD, Psychiatry Res., 226, 515, 10.1016/j.psychres.2015.01.028 · DOI
  27. Danne, 2014, ISPAD clinical practice consensus guidelines 2014. Insulin treatment in children and adolescents with diabetes, Pediatr. Diabetes, 15, 115, 10.1111/pedi.12184 · DOI
  28. Polanczyk, 2007, The worldwide prevalence of ADHD: a systematic review and metaregression analysis, Am. J. Psychiatry, 164, 942, 10.1176/ajp.2007.164.6.942 · DOI · Paper page
  29. Delamater, 2014, ISPAD clinical practice consensus guidelines 2014. Psychological care of children and adolescents with type 1 diabetes, Pediatr. Diabetes, 15, 232, 10.1111/pedi.12191 · DOI
  30. Herzer, 2010, Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control, J. Pediatr. Psychol., 35, 415, 10.1093/jpepsy/jsp063 · DOI
  31. Hood, 2006, Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics, Diabetes Care, 29, 1389, 10.2337/dc06-0087 · DOI · Paper page
  32. Greene, 2010, Metabolic control, self-care behaviors, and parenting in adolescents with type 1 diabetes: a correlational study, Diabetes Educ., 36, 326, 10.1177/0145721710361270 · DOI
  33. Lee, 2015, Predictors of Glycemic control in adolescents of various age groups with type 1 diabetes, J. Nurs. Res., 23, 271, 10.1097/JNR.0000000000000096 · DOI
  34. Limbers, 2011, Patient-reported Pediatric quality of life inventory 4.0 generic Core scales in pediatric patients with attention-deficit/hyperactivity disorder and comorbid psychiatric disorders: feasibility, reliability, and validity, Value Health, 14, 521, 10.1016/j.jval.2010.10.031 · DOI
  35. Coghill, 2016, Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls, Eur. Child Adolesc. Psychiatry, 25, 261, 10.1007/s00787-015-0728-y · DOI

Cited by

Sorted by citations

Metadata

Authors
Macek, J., Battelino, T., Bizjak, M., Zupanc, C., Bograf, A. K., Vesnic, S., Klemencic, S., Volk, E., & Bratina, N.
Affiliations
  • University of Ljubljana (SI)
  • Ljubljana University Medical Centre (SI)
ORCID
Battelino, Tadej
Venue
Journal of Psychosomatic Research
Publisher
Elsevier BV
Published
2019-11
Volume
126
Pages
109816
ISSN
0022-3999 (ISSN-L)
DOI
10.1016/j.jpsychores.2019.109816
OpenAlex
W2969312117
Cited by
16
References
1
Citations by year
2025: 3 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 1
FWCI
1.83
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Psychosomatic Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
attention deficit hyperactivity disorder, type 1 diabetes, adolescents, glycemic control, HbA1c, diabetes self-management, comorbidities, psychiatric comorbidity
MeSH terms
Adolescent, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Humans, Male, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review